Clinical Pharmacy
"Future RPh! Clinical Pharmacy is about patient-centered care. Hindi lang tayo nagbibigay ng gamot - tayo ang drug experts na nagpapayo sa doctors at nurses para sa safe and effective medication use. Laban lang, future clinical pharmacist!"
1. Introduction to Clinical Pharmacy 🏥
Clinical pharmacy focuses on the patient-centered approach to medication management. As a clinical pharmacist, you work directly with healthcare teams to optimize drug therapy outcomes.
Key Responsibilities of a Clinical Pharmacist:
- Drug therapy monitoring and optimization
- Patient counseling and medication education
- Drug information services to healthcare professionals
- Participation in medical rounds and case conferences
- Adverse drug reaction monitoring and reporting
- Development of formulary and drug use policies
Remember: Clinical pharmacy transforms the role of pharmacists from dispensing professionals to integral members of the healthcare team. Sa hospital setting, ikaw ang expert sa medications!
2. Medication Therapy Management (MTM) 💊
MTM is a systematic approach to optimize drug therapy outcomes. It involves reviewing all medications, identifying problems, and creating action plans.
| MTM Component | Description | Example Actions |
|---|---|---|
| Medication Therapy Review (MTR) | Comprehensive assessment of all medications | Check for duplications, interactions, appropriateness |
| Personal Medication Record (PMR) | Complete list of patient's medications | Document Rx, OTC, supplements, herbal products |
| Medication-Related Action Plan (MAP) | Patient-specific plan to address issues | Simplify regimen, address adherence barriers |
| Intervention and Referral | Actions taken and follow-up care | Contact physician, schedule follow-up |
| Documentation and Follow-up | Record keeping and outcome monitoring | Track progress, measure outcomes |
💡 Board Exam Tip:
MTM is a billable service in many healthcare systems. Know the 5 core elements and how they apply to patient care scenarios in board exam questions!
3. Drug-Related Problems (DRPs) ⚠️
DRPs are events involving drug therapy that actually or potentially interfere with desired health outcomes. Identifying and resolving DRPs is the core of clinical pharmacy practice.
| DRP Category | Description | Clinical Example |
|---|---|---|
| Unnecessary Drug Therapy | No medical indication | Antibiotics for viral infection |
| Needs Additional Therapy | Untreated condition | Diabetic without statin therapy |
| Ineffective Drug | Not producing desired effect | Antibiotic-resistant organism |
| Dosage Too Low | Subtherapeutic dose | Subtherapeutic warfarin (INR < 2) |
| Dosage Too High | Toxic dose | Digoxin toxicity (level > 2 ng/mL) |
| Adverse Drug Reaction | Harmful effect from drug | ACE inhibitor-induced cough |
| Drug Interaction | Drug-drug, drug-food interaction | Warfarin + NSAIDs = bleeding risk |
| Non-adherence | Patient not taking medication | Skipping doses due to cost |
Mnemonic: "INDENT ADN" - Indication, Need, Drug selection, Dose, Interactions, Adverse effects, ADherence, New problem
4. Pharmacovigilance and ADR Monitoring 🔍
Pharmacovigilance is the science of detecting, assessing, understanding, and preventing adverse effects from pharmaceutical products.
Types of Adverse Drug Reactions:
- Type A (Augmented): Predictable, dose-dependent (e.g., hypoglycemia from insulin)
- Type B (Bizarre): Unpredictable, not dose-related (e.g., penicillin allergy)
- Type C (Chronic): Long-term use effects (e.g., steroid-induced osteoporosis)
- Type D (Delayed): Occurs after time delay (e.g., teratogenicity)
- Type E (End of use): Withdrawal effects (e.g., opioid withdrawal)
- Type F (Failure): Therapeutic failure (e.g., OCP failure with rifampicin)
Naranjo Algorithm Scoring:
Used to assess causality of ADRs:
- Definite: Score ≥ 9
- Probable: Score 5-8
- Possible: Score 1-4
- Doubtful: Score ≤ 0
Questions include: previous reports, timing, dechallenge, rechallenge, alternative causes, etc.
FDA Philippines ADR Reporting:
Healthcare professionals are required to report ADRs to the FDA Philippines Center for Drug Regulation and Research (CDRR). Use Form FDA-ADR for reporting suspected adverse reactions.
5. Drug Interactions Management 💊⚡
Clinical pharmacists must identify, prevent, and manage drug interactions to ensure patient safety.
| Interaction Type | Mechanism | High-Yield Examples |
|---|---|---|
| Pharmacokinetic | Affects ADME | Rifampicin ↓ warfarin (CYP induction) |
| Pharmacodynamic | Same or opposite effects | Aspirin + warfarin = ↑ bleeding |
| Drug-Food | Food affects drug | Grapefruit + statins = toxicity |
| Drug-Disease | Drug worsens condition | Beta-blockers in asthma |
🔥 High-Yield CYP450 Interactions:
- CYP3A4 Inhibitors: Ketoconazole, Clarithromycin, Grapefruit juice
- CYP3A4 Inducers: Rifampicin, Phenytoin, Carbamazepine
- CYP2D6 Inhibitors: Fluoxetine, Paroxetine, Quinidine
- CYP2C9 Substrates: Warfarin, Phenytoin, Losartan
6. Therapeutic Drug Monitoring (TDM) 📊
TDM involves measuring drug concentrations to optimize dosing and minimize toxicity, especially for drugs with narrow therapeutic indices.
| Drug | Therapeutic Range | Toxic Signs | Monitoring Notes |
|---|---|---|---|
| Digoxin | 0.8-2.0 ng/mL | Nausea, yellow vision, arrhythmias | Draw 6-8 hrs post-dose |
| Phenytoin | 10-20 mcg/mL | Nystagmus, ataxia, confusion | Adjust for albumin/renal function |
| Vancomycin | Trough: 10-20 mcg/mL | Nephrotoxicity, ototoxicity | Draw trough before 4th dose |
| Aminoglycosides | Peak/Trough varies | Nephrotoxicity, ototoxicity | Extended interval dosing preferred |
| Lithium | 0.6-1.2 mEq/L | Tremor, polyuria, seizures | Draw 12 hrs post-dose |
| Theophylline | 10-20 mcg/mL | Tachycardia, seizures | Many drug interactions |
7. Practice Questions 📝
Question 1: Drug-Related Problem
A 65-year-old patient with diabetes and hypertension is taking metformin 500mg BID, lisinopril 10mg OD, and aspirin 80mg OD. He presents with persistent cough for 3 weeks. What is the most likely drug-related problem?
Answer: Adverse Drug Reaction - ACE inhibitor-induced cough. Lisinopril (ACE inhibitor) causes dry, persistent cough in 5-20% of patients due to bradykinin accumulation. Switch to an ARB (e.g., losartan) if cough persists.
Question 2: Therapeutic Drug Monitoring
A patient on vancomycin has a trough level of 25 mcg/mL. What is the appropriate action?
Answer: Hold the next dose and reassess. The level is supratherapeutic (>20 mcg/mL), increasing nephrotoxicity risk. Adjust the dose downward or extend the interval. Monitor serum creatinine.
Question 3: Drug Interaction
A patient on warfarin (INR stable at 2.5) is prescribed clarithromycin for respiratory infection. What should the pharmacist do?
Answer: Alert the physician about significant interaction. Clarithromycin inhibits CYP3A4 and CYP1A2, increasing warfarin levels and bleeding risk. Options: use alternative antibiotic (azithromycin is safer), reduce warfarin dose by 25-50%, or monitor INR closely (every 2-3 days).
Question 4: Naranjo Scale
A patient developed severe skin rash after starting allopurinol. The rash improved after stopping the drug. Using Naranjo algorithm, what causality category is this ADR?
Answer: Probable (Score 5-8). Points for: prior reports (+1), temporal relationship (+2), improvement after withdrawal (+1), reasonable alternative causes ruled out (+2). This is consistent with allopurinol-induced hypersensitivity syndrome.
Test Your Knowledge! 🧠
Ready ka na ba? Take the practice quiz for Clinical Pharmacy to reinforce what you just learned.
Start Practice Quiz 📝